PharmaCann has filed a notice of an exempt offering of securities to raise $18 Million in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, PharmaCann is raising up to $18,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brett Novey played a key…